Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric

Molecular Nutrition and Food Research

Volumn 57, Issue 9, 2013, Pages 1529-1542

  Aggarwal, Bharat B ^a   Yuan, Wei ^b   Li, Shiyou ^b   Gupta, Subash C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b STEPHEN F AUSTIN STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Cancer; Inflammation; Turmeric; Turmeric components

Indexed keywords

ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BISACURONE; CURCUMIN; CURDIONE; CYCLOHEXANOL DERIVATIVE; ELEMENE; FURAN DERIVATIVE; FURANODIENE; FUSED HETEROCYCLIC RINGS; GERMACRONE; SESQUITERPENE; TURMERIC;

ANIMAL; APOPTOSIS; CHEMISTRY; CLINICAL TRIAL (TOPIC); CURCUMA; DISEASE MODEL; HUMAN; INFLAMMATION; NEOPLASM; REVIEW; TURMERIC COMPONENTS;

APOPTOSIS; CANCER; INFLAMMATION; TURMERIC; TURMERIC COMPONENTS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CLINICAL TRIALS AS TOPIC; CURCUMA; CURCUMIN; CYCLOHEXANOLS; DISEASE MODELS, ANIMAL; FURANS; HETEROCYCLIC COMPOUNDS, 2-RING; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; NEOPLASMS; SESQUITERPENES; SESQUITERPENES, GERMACRANE;

EID: 84883346712     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200838     Document Type: Review

References (135)

1. Remadevi, R., Surendran, E., Kimura, T., Turmeric in traditional medicine. In: Ravindran, P. N., Babu, K. N., and Sivaraman, K. (Eds.), Turmeric, the Genus Curcuma, CRC Press, Taylor and Francis group, Boca Raton, New York 2007, pp. 409-436.
2. Gupta, S. C., Sung, B., Kim, J. H., Prasad, S. et al., Multitargeting by turmeric, the golden spice: from kitchen to clinic. Mol. Nutr. Food Res. 2013, 57, 1510-1528.
3. Prasad, S., Aggarwal, B. B., Turmeric, the Golden Spice: From Traditional Medicine to Modern Medicine, CRC Press, Boca Raton, FL 2012.
4. Arora, R. B., Kapoor, V., Basu, N., Jain, A. P., Anti-inflammatory studies on Curcuma longa (turmeric). Indian J. Med. Res. 1971, 59, 1289-1295.
5. Kuttan, R., Bhanumathy, P., Nirmala, K., George, M. C., Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett. 1985, 29, 197-202.
6. Kuttan, R., Sudheeran, P. C., Josph, C. D., Turmeric and curcumin as topical agents in cancer therapy. Tumori 1987, 73, 29-31.
7. Li, S. Y., Yuan, W., Deng, G. R., Wang, P. et al., Chemical composition and product quality control of turmeric (Curcuma longa L.). Pharmaceutical Crops 2011, 2, 28-54.
8. Han, G., Liu, Z. M., Wang, X. Y., Wang, Y. N., Study on effect of different extracts in curcuma long on stability of curcumin. Zhongguo Zhong Yao Za Zhi 2007, 32, 915-917.
9. Kiuchi, F., Goto, Y., Sugimoto, N., Akao, N. et al., Nematocidal activity of turmeric: synergistic action of curcuminoids. Chem. Pharm. Bull. (Tokyo) 1993, 41, 1640-1643.
10. Wang, L. Y., Zhang, M., Zhang, C. F., Wang, Z. T., Alkaloid and sesquiterpenes from the root tuber of Curcuma longa. Yao Xue Xue Bao 2008, 43, 724-727.
11. Li, W., Wang, S., Feng, J., Xiao, Y. et al., Structure elucidation and NMR assignments for curcuminoids from the rhizomes of Curcuma longa. Magn. Reson. Chem. 2009, 47, 902-908.
12. Garg, S. N., Bansal, R. P., Gupta, M. M., Kumar, S., Variation in the rhizome essential oil and curcumin contents and oil quality in the land races tumeric Curcuma longa of North Indian plains. Flavour Fragrance J. 1999, 14, 315-318.
13. Zeng, Y. C., Liang, J. M., Qu, G. X., Qiu, F., Chemical constituents of Curcuma longa I: bisabolane sesquiterpenes. Acta Pharmacologica Sinica 2007, 17, 738-741.
14. Wang, L. Y., Zhang, M., Zhang, C. F., Wang, Z. T., Alkaloid and sesquiterpenes from the root tuber of Curcuma longa. Acta Pharmacologica Sinica 2008, 43, 724-727.
15. Manzan, A. C., Toniolo, F. S., Bredow, E., Povh, N. P., Extraction of essential oil and pigments from Curcuma longa [L] by steam distillation and extraction with volatile solvents. J. Agric. Food Chem. 2003, 51, 6802-6807.
16. Ma, X., Gang, D. R., Metabolic profiling of turmeric (Curcuma longa L.) plants derived from in vitro micropropagation and conventional greenhouse cultivation. J. Agric. Food Chem. 2006, 54, 9573-9583.
17. Golding, B. T., Pombo, E., Christopher, J. S., Turmerones: isolation from turmeric and their structure determination. J. Chem. Soc. Chem. Commun. 1982, 6, 363-364.
18. Chowdhury, J. U., Nandi, N. C., Bhuiyan, M. N. I., Mobarok, M. H., Essential oil constituents of the rhizomes of two types of Curcuma longa of Bangladesh. Bangladesh J. Scientific Ind. Res. 2008, 43, 259-266.
19. Kim, J. H., Gupta, S. C., Park, B., Yadav, V. R. et al., Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-kappaB and NF-kappaB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. Mol. Nutr. Food Res. 2012, 56, 454-465.
20. Nishiyama, T., Mae, T., Kishida, H., Tsukagawa, M. et al., Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. J. Agric. Food Chem. 2005, 53, 959-963.
21. Selvam, R., Subramanian, L., Gayathri, R., Angayarkanni, N., The anti-oxidant activity of turmeric (Curcuma longa). J. Ethnopharmacol. 1995, 47, 59-67.
22. Mehra, K. S., Mikuni, I., Gupta, U., Gode, K. D., Curcuma longa (Linn) drops in corneal wound healing. Tokai J. Exp. Clin. Med. 1984, 9, 27-31.
23. Kim, H. J., Yoo, H. S., Kim, J. C., Park, C. S. et al., Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication. J. Ethnopharmacol. 2009, 124, 189-196.
24. Zaidi, S. F., Yamada, K., Kadowaki, M., Usmanghani, K. et al., Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori. J. Ethnopharmacol. 2009, 121, 286-291.
25. Mohankumar, S., McFarlane, J. R., An aqueous extract of Curcuma longa (turmeric) rhizomes stimulates insulin release and mimics insulin action on tissues involved in glucose homeostasis in vitro. Phytother. Res. 2011, 25, 396-401.
26. Yu, Z. F., Kong, L. D., Chen, Y., Antidepressant activity of aqueous extracts of Curcuma longa in mice. J. Ethnopharmacol. 2002, 83, 161-165.
27. Shalini, V. K., Srinivas, L., Lipid peroxide induced DNA damage: protection by turmeric (Curcuma longa). Mol. Cell Biochem. 1987, 77, 3-10.
28. Shalini, V. K., Srinivas, L., Fuel smoke condensate induced DNA damage in human lymphocytes and protection by turmeric (Curcuma longa). Mol. Cell Biochem. 1990, 95, 21-30.
29. Srinivas, L., Shalini, V. K., DNA damage by smoke: protection by turmeric and other inhibitors of ROS. Free Radic. Biol. Med. 1991, 11, 277-283.
30. Hu, B., Shen, K. P., An, H. M., Wu, Y. et al., Aqueous extract of Curcuma aromatica induces apoptosis and G2/M arrest in human colon carcinoma LS-174-T cells independent of p53. Cancer Biother. Radiopharm. 2011, 26, 97-104.
31. Azuine, M. A., Bhide, S. V., Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr. Cancer 1992, 17, 77-83.
32. Deshpande, S. S., Ingle, A. D., Maru, G. B., Inhibitory effects of curcumin-free aqueous turmeric extract on benzo[a]pyrene-induced forestomach papillomas in mice. Cancer Lett. 1997, 118, 79-85.
33. Deshpande, S. S., Ingle, A. D., Maru, G. B., Chemopreventive efficacy of curcumin-free aqueous turmeric extract in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumorigenesis. Cancer Lett. 1998, 123, 35-40.
34. Lantz, R. C., Chen, G. J., Solyom, A. M., Jolad, S. D. et al., The effect of turmeric extracts on inflammatory mediator production. Phytomedicine 2005, 12, 445-452.
35. Naganuma, M., Saruwatari, A., Okamura, S., Tamura, H., Turmeric and curcumin modulate the conjugation of 1-naphthol in Caco-2 cells. Biol. Pharm. Bull. 2006, 29, 1476-1479.
36. Tohda, C., Nakayama, N., Hatanaka, F., Komatsu, K., Comparison of anti-inflammatory activities of six curcuma rhizomes: a possible curcuminoid-independent pathway mediated by curcuma phaeocaulis extract. Evid. Based Complement Alternat. Med. 2006, 3, 255-260.
37. Suryanarayana, P., Saraswat, M., Mrudula, T., Krishna, T. P. et al., Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest. Ophthalmol. Vis. Sci. 2005, 46, 2092-2099.
38. Srinivas, L., Shalini, V. K., Shylaja, M., Turmerin: a water soluble antioxidant peptide from turmeric [Curcuma longa]. Arch. Biochem. Biophys. 1992, 292, 617-623.
39. Chethankumar, M., Anand, N., Gangadhara, N. S., Isolation and characterization of an antioxidant protein from Turmeric (Curcuma longa L.) peel waste: a new biological source. J. Pharm. Res. 2010, 3, 2659-2662.
40. Chethankumar, M., Srinivas, L., New biological activity against phospholipase A2 by Turmerin, a protein from Curcuma longa L. Biol. Chem. 2008, 389, 299-303.
41. Cohly, H. H. P., Asad, S., Das, S. K., Angel, M. F. et al., Effect of antioxidant (turmeric, turmerin and curcumin) on human immunodeficiency virus. Int. J. Mol. Sci. 2003, 4, 22-33.
42. Smitha, S., Dhananjaya, B. L., Dinesha, R., Srinivas, L., Purification and characterization of a approximately 34 kDa antioxidant protein (beta-turmerin) from turmeric (Curcuma longa) waste grits. Biochimie 2009, 91, 1156-1162.
43. Lekshmi, P. C., Arimboor, R., Raghu, K. G., Menon, A. N., Turmerin, the antioxidant protein from turmeric (Curcuma longa) exhibits antihyperglycaemic effects. Nat. Prod. Res. 2012, 26, 1654-1658.
44. Gopalan, B., Goto, M., Kodama, A., Hirose, T., Supercritical carbon dioxide extraction of turmeric (Curcuma longa). J. Agric. Food Chem. 2000, 48, 2189-2192.
45. Singh, G., Kapoor, I. P., Singh, P., de Heluani, C. S. et al., Comparative study of chemical composition and antioxidant activity of fresh and dry rhizomes of turmeric (Curcuma longa Linn.). Food. Chem. Toxicol. 2010, 48, 1026-1031.
46. Jayaprakasha, G. K., Jagan Mohan Rao, L., Sakariah, K. K., Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin. J. Agric. Food Chem. 2002, 50, 3668-3672.
47. Zhao, J., Zhang, J. S., Yang, B., Lv, G. P., Li, S. P., Free radical scavenging activity and characterization of sesquiterpenoids in four species of Curcuma using a TLC bioautography assay and GC-MS analysis. Molecules 2010, 15, 7547-7557.
48. Liju, V. B., Jeena, K., Kuttan, R., An evaluation of antioxidant, anti-inflammatory, and antinociceptive activities of essential oil from Curcuma longa. L. Indian J. Pharmacol. 2011, 43, 526-531.
49. Ferreira, L. A., Henriques, O. B., Andreoni, A. A., Vital, G. R. et al., Antivenom and biological effects of ar-turmerone isolated from Curcuma longa (Zingiberaceae). Toxicon 1992, 30, 1211-1218.
50. Roth, G. N., Chandra, A., Nair, M. G., Novel bioactivities of Curcuma longa constituents. J. Nat. Prod. 1998, 61, 542-545.
51. Negi, P. S., Jayaprakasha, G. K., Jagan Mohan Rao, L., Sakariah, K. K., Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. J. Agric. Food Chem. 1999, 47, 4297-4300.
52. Fujiwara, M., Yagi, N., Miyazawa, M., Acetylcholinesterase inhibitory activity of volatile oil from Peltophorum dasyrachis Kurz ex Bakar (yellow batai) and Bisabolane-type sesquiterpenoids. J. Agric. Food Chem. 2010, 58, 2824-2829.
53. Sandur, S. K., Pandey, M. K., Sung, B., Ahn, K. S. et al., Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 2007, 28, 1765-1773.
54. Leem, S. K., Hong, C. H., Huh, S. K., Kim, S. S. et al., Suppressive effect of natural sesquiterpenoids on inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) activity in mouse macrophage cells. J. Environ. Pathol. Toxicol. Oncol. 2002, 21, 141-148.
55. Hong, C. H., Noh, M. S., Lee, W. Y., Lee, S. K., Inhibitory effects of natural sesquiterpenoids isolated from the rhizomes of Curcuma zedoaria on prostaglandin E2 and nitric oxide production. Planta Med. 2002, 68, 545-547.
56. Aratanechemuge, Y., Komiya, T., Moteki, H., Katsuzaki, H. et al., Selective induction of apoptosis by ar-turmerone isolated from turmeric (Curcuma longa L) in two human leukemia cell lines, but not in human stomach cancer cell line. Int. J. Mol. Med. 2002, 9, 481-484.
57. Park, S. Y., Kim, Y. H., Kim, Y., Lee, S. J., Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-kappaB activation in TPA-induced breast cancer cells. J. Cell Biochem. 2012, 113, 3653-3662.
58. Park, S. Y., Kim, Y. H., Kim, Y., Lee, S. J., Aromatic-turmerone's anti-inflammatory effects in microglial cells are mediated by protein kinase A and heme oxygenase-1 signaling. Neurochem. Int. 2012, 61, 767-777.
59. Lee, H. S., Antiplatelet property of Curcuma longa L. rhizome-derived ar-turmerone. Bioresour. Technol. 2006, 97, 1372-1376.
60. Prakash, P., Misra, A., Surin, W. R., Jain, M. et al., Anti-platelet effects of Curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis. Thromb. Res. 2011, 127, 111-118.
61. Li, G., Xu, M. L., Lee, C. S., Woo, M. H. et al., Cytotoxicity and DNA topoisomerases inhibitory activity of constituents from the sclerotium of Poria cocos. Arch. Pharm. Res. 2004, 27, 829-833.
62. Lee, Y., Activation of apoptotic protein in U937 cells by a component of turmeric oil. BMB Rep. 2009, 42, 96-100.
63. Yue, G. G., Chan, B. C., Hon, P. M., Lee, M. Y. et al., Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa. Food Chem. Toxicol. 2010, 48, 2011-2020.
64. Cheng, S. B., Wu, L. C., Hsieh, Y. C., Wu, C. H. et al., Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. Induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 cells. J. Agric. Food Chem. 2012, 60, 9620-9630.
65. Onuma, K., Suenaga, Y., Sakaki, R., Yoshitome, S. et al., Development of a quantitative bioassay to assess preventive compounds against inflammation-based carcinogenesis. Nitric Oxide 2011, 25, 183-194.
66. Yonggang, T., Yiming, M., Heying, Z., Cheng, S. et al., Maturation and up-regulation of functions of murine dendritic cells (DCs) under the influence of purified Aromatic-Turmerone (AR). Hum. Vaccin. Immunother. 2012, 8, 1416-1424.
67. Kuroda, M., Mimaki, Y., Nishiyama, T., Mae, T. et al., Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. Biol. Pharm. Bull. 2005, 28, 937-939.
68. Lekshmi, P. C., Arimboor, R., Indulekha, P. S., Nirmala Menon, A., Turmeric (Curcuma longa L.) volatile oil inhibits key enzymes linked to type 2 diabetes. Int. J. Food Sci. Nutr. 2012, 63, 832-834.
69. Park, S. Y., Jin, M. L., Kim, Y. H., Kim, Y. et al., Aromatic-turmerone inhibits alpha-MSH and IBMX-induced melanogenesis by inactivating CREB and MITF signaling pathways. Arch. Dermatol. Res. 2011, 303, 737-744.
70. Antony, B., Merina, B., Iyer, V. S., Judy, N. et al., A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), a novel bioenhanced preparation of curcumin. Indian J. Pharm. Sci. 2008, 70, 445-449.
71. Yue, G. G., Cheng, S. W., Yu, H., Xu, Z. S. et al., The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells. J. Med. Food 2012, 15, 242-252.
72. Fu, N. W., Antitumor effect and pharmacological actions of beta-elemene isolated from the rhizome of Curcuma aromatica. Zhong Yao Tong Bao 1984, 9, 83-87.
73. Wang, G., Li, X., Huang, F., Zhao, J. et al., Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol. Life Sci. 2005, 62, 881-893.
74. Li, G., Xie, B., Li, X., Chen, Y. et al., Down-regulation of survivin and hypoxia-inducible factor-1 alpha by beta-elemene enhances the radiosensitivity of lung adenocarcinoma xenograft. Cancer Biother. Radiopharm. 2012, 27, 56-64.
75. Zhao, Y. F., Wang, C. R., Wu, Y. M., Ma, S. L. et al., P21 (waf1/cip1) is required for non-small cell lung cancer sensitive to Gefitinib treatment. Biomed. Pharmacother. 2011, 65, 151-156.
76. Xie, C. Y., Yang, W., Ying, J., Ni, Q. C. et al., B-cell lymphoma-2 over-expression protects delta-elemene-induced apoptosis in human lung carcinoma mucoepidermoid cells via a nuclear factor kappa B-related pathway. Biol. Pharm. Bull. 2011, 34, 1279-1286.
77. Zhang, F., Xu, L., Qu, X., Zhao, M. et al., Synergistic antitumor effect of beta-elemene and etoposide is mediated via induction of cell apoptosis and cell cycle arrest in non-small cell lung carcinoma cells. Mol. Med. Report 2011, 4, 1189-1193.
78. Li, X., Wang, G., Zhao, J., Ding, H. et al., Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. Cell Mol. Life Sci. 2005, 62, 894-904.
79. Tao, L., Zhou, L., Zheng, L., Yao, M., Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo. Cancer Chemother. Pharmacol. 2006, 58, 24-34.
80. Xu, L., Tao, S., Wang, X., Yu, Z. et al., The synthesis and anti-proliferative effects of beta-elemene derivatives with mTOR inhibition activity. Bioorg. Med. Chem. 2006, 14, 5351-5356.
81. Li, Q. Q., Wang, G., Huang, F., Banda, M. et al., Antineoplastic effect of beta-elemene on prostate cancer cells and other types of solid tumour cells. J. Pharm. Pharmacol. 2010, 62, 1018-1027.
82. Zhu, T., Xu, Y., Dong, B., Zhang, J. et al., Beta-elemene inhibits proliferation of human glioblastoma cells through the activation of glia maturation factor beta and induces sensitization to cisplatin. Oncol. Rep. 2011, 26, 405-413.
83. Zhu, T., Zhao, Y., Zhang, J., Li, L., et al., ss-Elemene inhibits proliferation of human glioblastoma cells and causes cell-cycle G0/G1 arrest via mutually compensatory activation of MKK3 and MKK6. Int. J. Oncol. 2011, 38, 419-426.
84. Yao, Y. Q., Ding, X., Jia, Y. C., Huang, C. X. et al., Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation. Cancer Lett. 2008, 264, 127-134.
85. Zhao, Y. S., Zhu, T. Z., Chen, Y. W., Yao, Y. Q. et al., Beta-elemene inhibits Hsp90/Raf-1 molecular complex inducing apoptosis of glioblastoma cells. J. Neurooncol. 2012, 107, 307-314.
86. Yu, Z., Wang, R., Xu, L., Xie, S. et al., beta-Elemene piperazine derivatives induce apoptosis in human leukemia cells through downregulation of c-FLIP and generation of ROS. PLoS One 2011, 6, e15843.
87. Yuan, J., Gu, Z. L., Chou, W. H., Kwok, C. Y., Elemene induces apoptosis and regulates expression of bcl-2 protein in human leukemia K562 cells. Zhongguo Yao Li Xue Bao 1999, 20, 103-106.
88. Yu, Z., Wang, R., Xu, L., Dong, J. et al., N-(beta-Elemene-13-yl)tryptophan methyl ester induces apoptosis in human leukemia cells and synergizes with arsenic trioxide through a hydrogen peroxide dependent pathway. Cancer Lett. 2008, 269, 165-173.
89. Ying, J., Yang, W., Xie, C. Y., Ni, Q. C. et al., Induction of caspase-3-dependent apoptosis in human leukemia HL-60 cells by delta-elemene. Yakugaku Zasshi 2011, 131, 1383-1394.
90. Zhang, B., Zhang, X., Tang, B., Zheng, P. et al., Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor alpha (ERalpha) re-expression. Breast Cancer Res. Treat. 2012, 136, 399-406.
91. Xie, C. Y., Yang, W., Li, M., Ying, J. et al., Cell apoptosis induced by delta-elemene in colorectal adenocarcinoma cells via a mitochondrial-mediated pathway. Yakugaku Zasshi 2009, 129, 1403-1413.
92. Wu, X. S., Xie, T., Lin, J., Fan, H. Z. et al., An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas. J. Pharm. Pharmacol. 2009, 61, 1653-1656.
93. Bao, F., Qiu, J., Zhang, H., Potential role of beta-elemene on histone H1 in the H22 ascites hepatoma cell line. Mol. Med. Report 2012, 6, 185-190.
94. Chen, W., Lu, Y., Wu, J., Gao, M. et al., Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis. Cancer Chemother. Pharmacol. 2011, 67, 799-808.
95. Wang, K., Li, Z., Chen, Y., Su, C., The pharmacokinetics of a novel anti-tumor agent, beta-elemene, in Sprague-Dawley rats. Biopharm. Drug Dispos. 2005, 26, 301-307.
96. Zhang, R., Tian, A., Shi, X., Yu, H. et al., Downregulation of IL-17 and IFN-gamma in the optic nerve by beta-elemene in experimental autoimmune encephalomyelitis. Int. Immunopharmacol. 2010, 10, 738-743.
97. Lima, D. K., Ballico, L. J., Rocha Lapa, F., Goncalves, H. P. et al., Evaluation of the antinociceptive, anti-inflammatory and gastric antiulcer activities of the essential oil from Piper aleyreanum C.DC in rodents. J. Ethnopharmacol. 2012, 142, 274-282.
98. Liu, J., Zhang, Z., Gao, J., Xie, J. et al., Downregulation effects of beta-elemene on the levels of plasma endotoxin, serum TNF-alpha, and hepatic CD14 expression in rats with liver fibrosis. Front Med. 2011, 5, 101-105.
99. Tang, X., Qin, S., Xie, T., Status and progress of basic researches of elemene injection for anti-tumor. Chinese Clin. Oncol. 2010, 15, 266-273.
100. Makabe, H., Maru, N., Kuwabara, A., Kamo, T. et al., Anti-inflammatory sesquiterpenes from Curcuma zedoaria. Nat. Prod. Res. 2006, 20, 680-685.
101. Xiao, Y., Yang, F. Q., Li, S. P., Gao, J. L. et al., Furanodiene induces G2/M cell cycle arrest and apoptosis through MAPK signaling and mitochondria-caspase pathway in human hepatocellular carcinoma cells. Cancer Biol. Ther. 2007, 6, 1044-1050.
102. Ma, E., Wang, X., Li, Y., Sun, X. et al., Induction of apoptosis by furanodiene in HL60 leukemia cells through activation of TNFR1 signaling pathway. Cancer Lett. 2008, 271, 158-166.
103. Sun, X. Y., Zheng, Y. P., Lin, D. H., Zhang, H. et al., Potential anti-cancer activities of Furanodiene, a Sesquiterpene from Curcuma wenyujin. Am. J. Chin. Med. 2009, 37, 589-596.
104. Chen, X., Pei, L., Zhong, Z., Guo, J. et al., Anti-tumor potential of ethanol extract of Curcuma phaeocaulis Valeton against breast cancer cells. Phytomedicine 2011, 18, 1238-1243.
105. Zhong, Z., Dang, Y., Yuan, X., Guo, W. et al., Furanodiene, a natural product, inhibits breast cancer growth both in vitro and in vivo. Cell Physiol. Biochem. 2012, 30, 778-790.
106. Zhong, Z. F., Hoi, P. M., Wu, G. S., Xu, Z. T. et al., Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo. J. Ethnopharmacol. 2012, 141, 721-727.
107. Pei, L., Liu, S., Zheng, J., Chen, X., A sensitive method for determination of furanodiene in rat plasma using liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study. Biomed. Chromatogr. 2012, 26, 826-832.
108. Oh, O. J., Min, H. Y., Lee, S. K., Inhibition of inducible prostaglandin E2 production and cyclooxygenase-2 expression by curdione from Curcuma zedoaria. Arch. Pharm. Res. 2007, 30, 1236-1239.
109. Sun, D. I., Nizamutdinova, I. T., Kim, Y. M., Cai, X. F. et al., Bisacurone inhibits adhesion of inflammatory monocytes or cancer cells to endothelial cells through down-regulation of VCAM-1 expression. Int. Immunopharmacol. 2008, 8, 1272-1281.
110. Simon, A., Allais, D. P., Duroux, J. L., Basly, J. P. et al., Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationships. Cancer Lett. 1998, 129, 111-116.
111. Adhikary, R., Barnes, C. A., Trampel, R. L., Wallace, S. J. et al., Photoinduced trans-to-cis isomerization of cyclocurcumin. J. Phys. Chem. B 2011, 115, 10707-10714.
112. Li, Y., Li, S., Han, Y., Liu, J. et al., Calebin-A induces apoptosis and modulates MAPK family activity in drug resistant human gastric cancer cells. Eur. J. Pharmacol. 2008, 591, 252-258.
113. Kim, D. S., Kim, J. Y., Total synthesis of Calebin-A, preparation of its analogues, and their neuronal cell protectivity against beta-amyloid insult. Bioorg. Med. Chem. Lett. 2001, 11, 2541-2543.
114. Zhong, Z., Chen, X., Tan, W., Xu, Z. et al., Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis. Eur. J. Pharmacol. 2011, 667, 50-55.
115. Liu, Y., Wang, W., Fang, B., Ma, F. et al., Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. Eur. J. Pharmacol. 2013, 698, 95-102.
116. Suphrom, N., Pumthong, G., Khorana, N., Waranuch, N. et al., Anti-androgenic effect of sesquiterpenes isolated from the rhizomes of Curcuma aeruginosa Roxb. Fitoterapia 2012, 83, 864-871.
117. Peng, B. X., Zhou, X., Shi, J. S., Li, Z. W., Effects of volatile oil and three main components from Curcuma phaeocaulis Valeton on liver cancer and endometrial carcinoma cell. Huaxi Yaoxue Zazhi 2007, 22, 312-313.
118. Sun, D. X., Fang, Z. Z., Zhang, Y. Y., Cao, Y. F. et al., Inhibitory effects of curcumenol on human liver cytochrome P450 enzymes. Phytother. Res. 2010, 24, 1213-1216.
119. Ozaki, Y., Antiinflammatory effect of Curcuma xanthorrhiza Roxb, and its active principles. Chem. Pharm. Bull. (Tokyo) 1990, 38, 1045-1048.
120. Claeson, P., Panthong, A., Tuchinda, P., Reutrakul, V. et al., Three non-phenolic diarylheptanoids with anti-inflammatory activity from Curcuma xanthorrhiza. Planta Med. 1993, 59, 451-454.
121. Matsuda, H., Ninomiya, K., Morikawa, T., Yoshikawa, M., Inhibitory effect and action mechanism of sesquiterpenes from Zedoariae Rhizoma on D-galactosamine/lipopolysaccharide-induced liver injury. Bioorg. Med. Chem. Lett. 1998, 8, 339-344.
122. Morikawa, T., Matsuda, H., Ninomiya, K., Yoshikawa, M., Medicinal foodstuffs. XXIX. Potent protective effects of sesquiterpenes and curcumin from Zedoariae Rhizoma on liver injury induced by D-galactosamine/lipopolysaccharide or tumor necrosis factor-alpha. Biol. Pharm. Bull. 2002, 25, 627-631.
123. Bamba, Y., Yun, Y. S., Kunugi, A., Inoue, H., Compounds isolated from Curcuma aromatica Salisb. inhibit human P450 enzymes. J. Nat. Med. 2011, 65, 583-587.
124. Efferth, T., Olbrich, A., Sauerbrey, A., Ross, D. D. et al., Activity of ascaridol from the anthelmintic herb Chenopodium anthelminticum L. against sensitive and multidrug-resistant tumor cells. Anticancer Res 2002, 22, 4221-4224.
125. Liu, R., Zhang, L., Lan, X., Li, L. et al., Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion: involvement of anti-oxidation and anti-inflammation through nuclear transcription factor kappaappaB signaling pathway. Neuroscience 2011, 176, 408-419.
126. Koparal, A. T., Zeytinoglu, M., Effects of carvacrol on a human non-small cell lung cancer (NSCLC) cell line, A549. Cytotechnology 2003, 43, 149-154.
127. Arunasree, K. M., Anti-proliferative effects of carvacrol on a human metastatic breast cancer cell line, MDA-MB 231. Phytomedicine 2010, 17, 581-588.
128. Raphael, T. J., Kuttan, G., Effect of naturally occurring monoterpenes carvone, limonene and perillic acid in the inhibition of experimental lung metastasis induced by B16F-10 melanoma cells. J. Exp. Clin. Cancer Res. 2003, 22, 419-424.
129. Xie, G., Chen, N., Soromou, L. W., Liu, F. et al., p-Cymene protects mice against lipopolysaccharide-induced acute lung injury by inhibiting inflammatory cell activation. Molecules 2012, 17, 8159-8173.
130. Vinothkumar, V., Manoharan, S., Sindhu, G., Nirmal, M. R. et al., Geraniol modulates cell proliferation, apoptosis, inflammation, and angiogenesis during 7, 12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Mol. Cell Biochem. 2012, 369, 17-25.
131. Salminen, A., Lehtonen, M., Suuronen, T., Kaarniranta, K. et al., Terpenoids: natural inhibitors of NF-kappaB signaling with anti-inflammatory and anticancer potential. Cell Mol. Life Sci. 2008, 65, 2979-2999.
132. Gu, Y., Ting, Z., Qiu, X., Zhang, X. et al., Linalool preferentially induces robust apoptosis of a variety of leukemia cells via upregulating p53 and cyclin-dependent kinase inhibitors. Toxicology 2010, 268, 19-24.
133. Matsuo, A. L., Figueiredo, C. R., Arruda, D. C., Pereira, F. V. et al., alpha-Pinene isolated from Schinus terebinthifolius Raddi (Anacardiaceae) induces apoptosis and confers antimetastatic protection in a melanoma model. Biochem. Biophys. Res. Commun. 2011, 411, 449-454.
134. Okumura, N., Yoshida, H., Nishimura, Y., Kitagishi, Y. et al., Terpinolene, a component of herbal sage, downregulates AKT1 expression in K562 cells. Oncol. Lett. 2012, 3, 321-324.
135. Deb, D. D., Parimala, G., Saravana Devi, S., Chakraborty, T., Effect of thymol on peripheral blood mononuclear cell PBMC and acute promyelotic cancer cell line HL-60. Chem. Biol. Interact. 2011, 193, 97-106.